BS. Keep trying to spin today's good news as negat
Post# of 72440
Even if it only works for 40% of the appropriate patient cohort, that is huge. An oral drug with a much better safety profile than biologics -- no needles, few side effects..... This will be the first drug people try.
And remember, genuine CTIX bulls, this succeeded for some patients whose treatments with other drugs failed.